- ISIN
- US7133171055
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- May 6, 2022
Highlights
- Market Cap
- $168.77M
- Enterprise Value
- $146.39M
- EPS (TTM)
- -$1.61
- Gross Profit (TTM)
- -$1.40M
- EBITDA (TTM)
- -$62.22M
- Year Range
- $1.01 - $7.80
- Target Price
- $7.00
- ROA (TTM)
- -49.40%
- ROE (TTM)
- -57.63%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PEPG Performance Chart
PepGen Ltd (PEPG) is down 62.5% since the beginning of the year. At $2 per share, PEPG is trading 68.7% below its 52-week high of $8.
Loading charts...
Returns By Period
PepGen Ltd (PEPG) has returned -62.52% so far this year and 93.65% over the past 12 months.
PepGen Ltd
- 1D
- 4.27%
- 1M
- 65.99%
- 6M
- -57.04%
- YTD
- -62.52%
- 1Y
- 93.65%
- 3Y*
- -32.85%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.79%
- 1M
- 1.13%
- 6M
- 7.71%
- YTD
- 9.79%
- 1Y
- 20.06%
- 3Y*
- 18.60%
- 5Y*
- 11.43%
- 10Y*
- 13.27%
PEPG Monthly Returns History
Based on dividend-adjusted daily data since May 6, 2022, PEPG's average daily return is +0.17%, while the average monthly return is +5.38%. At this rate, an investment would double in approximately 1.1 years.
Historically, 41% of months were positive and 59% were negative. The best month was Sep 2025 with a return of +298.3%, while the worst month was Mar 2026 at -71.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, PEPG closed higher 47% of trading days. The best single day was Sep 25, 2025 with a return of +121.1%, while the worst single day was Mar 31, 2026 at -58.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -21.20% | 21.25% | -71.54% | -7.34% | -8.54% | 20.00% | 35.56% | -62.52% | |||||
| 2025 | -65.96% | 144.19% | -55.40% | 11.74% | -7.01% | -23.97% | 23.42% | -15.33% | 298.28% | 0.87% | 38.20% | 1.09% | 71.77% |
| 2024 | 47.50% | 68.99% | -13.27% | -16.46% | 32.98% | -2.27% | -28.38% | -15.75% | -11.21% | -22.57% | -23.72% | -24.95% | -44.26% |
| 2023 | 16.83% | -2.24% | -19.91% | 23.39% | -0.73% | -40.32% | -33.00% | 5.18% | -19.37% | 0.79% | -4.30% | 38.78% | -49.14% |
| 2022 | -28.27% | -11.26% | 12.79% | -15.18% | -4.42% | 35.24% | 21.82% | -10.63% | -14.29% |
Benchmark Metrics
PepGen Ltd has an annualized alpha of 30.54%, beta of 1.08, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since May 06, 2022.
- This stock participated in 232.28% of S&P 500 Index downside but only 34.64% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 30.54%
- Beta
- 1.08
- R²
- 0.02
- Upside Capture
- 34.64%
- Downside Capture
- 232.28%
Return for Risk
Risk / Return Rank
PEPG ranks 74 for risk / return — better than 74% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for PepGen Ltd (PEPG) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PEPG | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.05 | ||
| Sortino ratioReturn per unit of downside risk | 0.00 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.29 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.16 | 2.21 | -1.05 |
| Martin ratioReturn relative to average drawdown | 2.16 | 9.61 | -7.44 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the PepGen Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the PepGen Ltd was 94.61%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current PepGen Ltd drawdown is 86.85%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -94.61%Apr 2025 | 8mo 13d | — | 1y 11moJul 2024 - now |
2023 bear market2023 | -78.19%Nov 2023 | 7mo 25d | 6mo 28d | 1y 2moMar 2023 - Jun 2024 |
Bear market2022 | -68.85%Sep 2022 | 4mo 18d | 1mo 27d | 6mo 15dMay 2022 - Nov 2022 |
2023 bear market2023 | -22.43%Mar 2023 | 27d | 4d | 1mo 1dFeb 2023 - Mar 2023 |
2023 correction2023 | -19.55%Jan 2023 | 1mo 12d | 17d | 1mo 29dNov 2022 - Jan 2023 |
Drawdown Indicators
| PEPG | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -56.78% | -37.83% |
Max Drawdown (1Y)Largest decline over 1 year | -81.17% | -9.10% | -72.07% |
Max Drawdown (3Y)Largest decline over 3 years | -94.61% | -18.90% | -75.71% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -86.85% | -1.24% | -85.61% |
Average DrawdownAverage peak-to-trough decline | -54.62% | -10.71% | -43.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.42% | 2.09% | +41.33% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of PepGen Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how PepGen Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PEPG in comparison with other companies in the Biotechnology industry. Currently, PEPG has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PEPG
Add PepGen Ltd to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PEPG